Spironolactone, a therapeutic alternative in the treatment of diffuse retinal pigment epitheliopathy

Abstract

Case report: Two cases are presented of patients with chronic diffuse epitheliopathy (CDE) that showed a favourable response when treated with spironolactone. The first patient had regions of neurosensory detachment (DNS) and the second, multiple DNS, secondary intra-retinal cysts and retinal pigment epithelium detachment.

Discussion: After treatment with spironolactone, both patients showed a visual acuity improvement and structural changes (reduced neurosensory retinal detachment and cystoid degeneration). Aldosterone receptor agonists (ARA) used for persistent forms of chronic central serous chorioretinopathy show encouraging results and could represent a therapeutic alternative for CDE.

Keywords: Aldosterona; Aldosterone; Antagonistas; Antagonists; Chronic; Crónica; Diffuse; Difusa; Epiteliopatía; Epitheliopathy; Espironolactona; Receptor; Receptores; Spironolactone.